Metraipolis › archive › dc_b71876282f4e

Methotrexate-Loaded Liposomal Formulation Enables 6-Week Sustained Intraocular Therapeutic Drug Release in a Porcine Model — Europe PMC PMID:40999813

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40999813
DOI: 10.1002/adhm.202503230
License (as archived): solo-consultazione
Archived: 2026-11-09T18:28:30.342Z
SHA-256 of the archived text: 928d3f83924a16feca1331be0f5837e98c0799e0b0726a02be9b336dfcb4fdf1
Stable URL of this page: https://metraipolis.com/documento/dc_b71876282f4e

How to cite

Methotrexate-Loaded Liposomal Formulation Enables 6-Week Sustained Intraocular Therapeutic Drug Release in a Porcine Model — Europe PMC PMID:40999813 — Europe PMC (en), https://europepmc.org/article/MED/40999813 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b71876282f4e (Metraipolis archive dc_b71876282f4e, sha256 928d3f83924a16feca1331be0f5837e98c0799e0b0726a02be9b336dfcb4fdf1)

BibTeX

@misc{dcb71876282f4e,
  title = {Methotrexate-Loaded Liposomal Formulation Enables 6-Week Sustained Intraocular Therapeutic Drug Release in a Porcine Model — Europe PMC PMID:40999813},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40999813},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b71876282f4e; sha256 928d3f83924a16feca1331be0f5837e98c0799e0b0726a02be9b336dfcb4fdf1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40999813. Agents can read the archived copy with the MCP tool read_document.